Pair Of Life Science Cos. Raise Combined $247M In IPOs
Life science companies Harmony Biosciences and Inhibrx went public Wednesday after raising a combined $247 million as the sector continues to dominate initial public offering launches....To view the full article, register now.
Already a subscriber? Click here to view full article